Value Sense
PG
The Procter & Gamble Company (PG)
Last Price$175.61.0%
Market Cap$411.8B
LTM Research & Development Expenses (R&D)
$0.0
YoY Growth
N/A
3Y CAGR
N/A
5Y CAGR
N/A
Stock quality & Intrinsic value
7/10
22.6% overvalued
PG
is (22.6%) overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

The Procter & Gamble Company Research & Development Expenses (R&D)

Annual
Quarterly
LTM
Crunching data... Almost there!
Jun'05Jun'06Jun'07Jun'08Jun'09Jun'10Jun'11Jun'12Jun'13Jun'14Jun'15Jun'16Jun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24
Research & Development Expenses (R&D)
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
PG
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for PG and see if it's the right time to invest.
Dive in

The Procter & Gamble Company (PG) Research & Development Expenses (R&D) comparison analysis

General

LTM Research & Development Expenses (R&D)

Growth

Company name

YoY growth

3Y CAGR

5Y CAGR

The Procter & Gamble Company logo
The Procter & Gamble CompanyPG
$0.0
N/A
N/A
N/A
Median Peer Set
$102.8M
(24.9%)
(2.1%)
(0.7%)
Unilever PLC logo
Unilever PLCUL
$1,026.6M
(44.5%)
(19.2%)
(13.8%)
The Estée Lauder Companies Inc. logo
The Estée Lauder Companies Inc.EL
$360.0M
4.7%
N/A
12.3%
Kenvue Inc. logo
Kenvue Inc.KVUE
$205.0M
(48.6%)
26.2%
N/A
The Clorox Company logo
The Clorox CompanyCLX
$127.0M
(5.2%)
(4.1%)
(1.4%)
Coty Inc. logo
Coty Inc.COTY
$126.8M
20.5%
9.5%
N/A
Hims & Hers Health, Inc. logo
Hims & Hers Health, Inc.HIMS
$78.8M
63.4%
88.3%
N/A
Church & Dwight Co., Inc. logo
Church & Dwight Co., Inc.CHD
$63.1M
(48.4%)
(15.7%)
(7.6%)
e.l.f. Beauty, Inc. logo
e.l.f. Beauty, Inc.ELF
$0.0
N/A
N/A
N/A
Colgate-Palmolive Company logo
Colgate-Palmolive CompanyCL
$0.0
(100.0%)
(100.0%)
(100.0%)
Kimberly-Clark Corporation logo
Kimberly-Clark CorporationKMB
$0.0
(100.0%)
(100.0%)
(100.0%)

PG key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Jun'05Jun'06Jun'07Jun'08Jun'09Jun'10Jun'11Jun'12Jun'13Jun'14Jun'15Jun'16Jun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24
Revenue
% growth
56,741.0
10.4%
68,222.0
20.2%
76,476.0
12.1%
81,748.0
6.9%
76,694.0
(6.2%)
77,567.0
1.1%
81,104.0
4.6%
82,006.0
1.1%
80,116.0
(2.3%)
74,401.0
(7.1%)
70,749.0
(4.9%)
65,299.0
(7.7%)
65,058.0
(0.4%)
66,832.0
2.7%
67,684.0
1.3%
70,950.0
4.8%
76,118.0
7.3%
80,187.0
5.3%
82,006.0
2.3%
84,039.0
2.5%
Cost of Goods Sold (COGS)27,872.033,125.036,686.039,536.038,690.037,042.039,859.041,411.039,991.039,030.037,056.032,909.032,638.034,432.034,768.035,250.037,108.042,157.042,760.040,848.0
Gross Profit
% margin
28,869.0
50.9%
35,097.0
51.4%
39,790.0
52.0%
42,212.0
51.6%
38,004.0
49.6%
40,525.0
52.2%
41,245.0
50.9%
40,595.0
49.5%
40,125.0
50.1%
35,371.0
47.5%
33,693.0
47.6%
32,390.0
49.6%
32,420.0
49.8%
32,400.0
48.5%
32,916.0
48.6%
35,700.0
50.3%
39,010.0
51.2%
38,030.0
47.4%
39,246.0
47.9%
43,191.0
51.4%
Operating Expenses18,400.021,848.024,340.025,575.022,630.024,793.025,750.027,560.026,308.021,461.022,644.018,949.018,654.019,037.027,429.019,994.021,024.020,217.021,112.024,646.0
Research & Development Expenses (R&D)0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)18,400.021,848.024,340.025,575.022,630.024,793.025,750.025,984.026,000.021,461.020,616.018,949.018,654.019,037.019,084.019,994.021,024.020,217.021,112.023,305.0
Operating Income
% margin
10,469.0
18.5%
13,249.0
19.4%
15,450.0
20.2%
16,637.0
20.4%
15,374.0
20.0%
15,732.0
20.3%
15,495.0
19.1%
13,035.0
15.9%
13,817.0
17.2%
13,910.0
18.7%
11,049.0
15.6%
13,441.0
20.6%
13,766.0
21.2%
13,363.0
20.0%
5,487.0
8.1%
15,706.0
22.1%
17,986.0
23.6%
17,813.0
22.2%
18,134.0
22.1%
18,545.0
22.1%
Interest Income0.00.00.00.00.00.062.077.088.099.0149.0182.0171.0247.0220.0155.045.051.0307.0473.0
Interest Expense0.00.00.01,467.01,358.0946.0831.0769.0667.0709.0626.0579.0465.0506.0509.0465.0502.0439.0756.0925.0
Pre-tax Income9,981.012,413.014,710.015,632.014,413.014,868.014,997.012,528.014,179.013,509.011,012.013,369.013,257.013,326.06,069.015,834.017,615.017,995.018,353.018,761.0
Income Tax
% effective tax rate
3,058.0
30.6%
3,729.0
30.0%
4,370.0
29.7%
3,834.0
24.5%
3,733.0
25.9%
4,017.0
27.0%
3,299.0
22.0%
3,378.0
27.0%
3,226.0
22.8%
2,851.0
21.1%
2,725.0
24.7%
3,342.0
25.0%
3,063.0
23.1%
3,465.0
26.0%
2,103.0
34.7%
2,731.0
17.2%
3,263.0
18.5%
3,202.0
17.8%
3,615.0
19.7%
3,787.0
20.2%
Net Income
% margin
6,923.0
12.2%
8,684.0
12.7%
10,340.0
13.5%
12,075.0
14.8%
13,436.0
17.5%
12,736.0
16.4%
11,797.0
14.5%
10,756.0
13.1%
11,312.0
14.1%
11,643.0
15.6%
7,036.0
9.9%
10,508.0
16.1%
15,326.0
23.6%
9,750.0
14.6%
3,897.0
5.8%
13,027.0
18.4%
14,306.0
18.8%
14,742.0
18.4%
14,653.0
17.9%
14,879.0
17.7%
EPS2.702.793.223.864.494.324.123.824.044.192.503.805.803.851.565.135.696.006.076.30
Diluted EPS2.532.643.043.644.264.113.933.663.864.012.443.695.593.671.534.965.505.815.906.02
EBITDA
% margin
12,353.0
21.8%
15,876.0
23.3%
18,580.0
24.3%
20,265.0
24.8%
18,853.0
24.6%
18,922.0
24.4%
18,666.0
23.0%
16,501.0
20.1%
17,828.0
22.3%
17,359.0
23.3%
14,772.0
20.9%
17,026.0
26.1%
16,542.0
25.4%
16,666.0
24.9%
9,402.0
13.9%
19,312.0
27.2%
20,852.0
27.4%
21,241.0
26.5%
21,823.0
26.6%
22,582.0
26.9%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is The Procter & Gamble Company's Research & Development Expenses (R&D)?

As of today, The Procter & Gamble Company's last 12-month Research & Development Expenses (R&D) is $0.0, based on the financial report for Dec 31, 2024 (Q4’2024).

2) What is The Procter & Gamble Company's Research & Development Expenses (R&D) growth rate?

Over the last year, The Procter & Gamble Company's Research & Development Expenses (R&D) growth was N/A. The average annual Research & Development Expenses (R&D) growth rates for The Procter & Gamble Company have been N/A over the past three years, N/A over the past five years.